Patients and healthcare professionals are reminded to report any suspected adverse reactions to medicines, including those experienced within clinical trials, via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app
PMID: 5 AlharbiSH
Yes, pairing tirzepatide with a structured nutrition plan significantly improves outcomes and helps preserve lean muscle mass during weight loss
Apr 25, 2025, 09:30 ET Federal court ruling leaves in place FDA's decision resolving the shortage of Wegovy and Ozempic , which are fully available nationwide, and ends the grace period for pharmacies to make or sell compounded "versions" of these medicines Separate federal court ruling permanently bars MediOak Pharmacy LLC from marketing or selling illegitimate "semaglutide" drugs Legal wins build on 111 lawsuits filed by Novo Nordisk across 32 states against entities unlawfully marketing and selling compounded "semaglutide" drugs, helping safeguard Americans from knockoffs made with unsafe or illicit foreign API Novo Nordisk is dedicated to dialogue with companies to support patient access to authentic, FDA-approved Wegovy under the care of a licensed healthcare professional PLAINSBORO, N.J., April 25, 2025 /PRNewswire/ -- Yesterday, a Texas federal court ruled in favor of Novo Nordisk and FDA, denying a compounding trade association's motion to freeze the FDA's decision to end the shortage of semaglutide injectable medicines
Most Favored Nation Pricing: The 2025 Executive Orders Patent Strategy Implications On May 12, 2025, the White House issued an Executive Order directing the Secretary of HHS to pursue most-favored-nation prescription drug pricing
